Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Mod GRF 1-29

Sermorelin, Growth Hormone Releasing Hormone (1-29), hGRF(1-29)NH2

Quick Stats
Studies 227
Trials 47
Score 2
1990 pubmed

Sex difference in growth hormone feedback in the rat.

Carlsson. L M LM; Clark. R G RG; Robinson. I C IC

Key Findings

  • Female rats maintain consistent GH spikes after multiple GRF‑1‑29 injections during GH infusion, unlike males.
  • Male rats show an intermittent, 3‑hour pattern of GH response that becomes prolonged when GH is infused.
  • The sex‑specific feedback may be due to GH‑induced changes in somatostatin release patterns.

Practical Outcomes

  • For biohackers, the study suggests that sex may influence how the body reacts to GRF‑1‑29, hinting that dosing schedules could differ between men and women. However, because the work is in rats and focuses on hormonal feedback mechanisms, it doesn’t provide direct, ready‑to‑use protocols for humans. More human research is needed before adjusting GRF‑1‑29 regimens based on these findings.

Summary

In rats, giving growth hormone (GH) changes how the body responds to the hormone‑releasing peptide GRF‑1‑29, and this effect is different between males and females. Female rats keep responding strongly to repeated GRF‑1‑29 shots even while GH is infused, while male rats become less responsive in a regular 3‑hour cycle that gets stretched out by GH. The researchers think this is because GH alters the release of somatostatin (a hormone that blocks GH) differently in the two sexes.

Abstract

Growth hormone inhibits its own secretion in animals and man but the mechanism for this inhibition is unclear: both stimulation of somatostatin release and inhibition of GH-releasing factor (GRF) release have been implicated. We have now studied the GRF responsiveness of conscious male and female rats under conditions of GH feedback induced by constant infusion of exogenous human GH (hGH). Intravenous infusions of hGH (60 micrograms/h) were maintained for 3 to 6 h whilst serial injections of GRF(1-29)NH2 (0.2-1 microgram) were given at 45-min intervals. The GH responses were studied by assaying blood samples withdrawn at frequent intervals using an automatic blood sampling system. We have confirmed that male and female rats differ in their ability to respond to a series of GRF injections; female rats produced consistent GH responses for up to 13 consecutive GRF injections, whereas male rats showed a 3-hourly pattern of intermittent responsiveness. In female rats, multiple injections of GRF continued to elicit uniform GH responses during hGH infusions, whereas hGH infusions in male rats disturbed their intermittent pattern of responsiveness to GRF, and their regular 3-hourly cycle of refractoriness was prolonged. We suggest that this sex difference in GH feedback may be due to GH altering the pattern of endogenous somatostatin release differentially in male and female rats. Such a mechanism of GH autofeedback could be involved in the physiological control of the sexually differentiated pattern of GH secretion in the rat.

Study Information

Provider

pubmed

Year

1990

DOI

10.1677/joe.0.1260027